Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
US10894963B2 · kind B2 · utility
5Cited by
144References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2014 |
| Grant date | Jan 19, 2021 |
| Priority date | — |
| Expiry date | Feb 13, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Aspects of the invention relate to spherical nucleic acid-based constructs and related methods and compositions thereof. The compositions of the invention are useful for activating agonists of nucleic acid interacting complexes, such as TLRs, stimulating an immune response, and treating diseases such as infectious disease, cancer, allergies, allergic diseases, and autoimmune disease
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.